A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)

Clinical trial NCT07566429 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07566429
Sponsor: Bayer
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2027-01-25
Primary completion: 2029-06-15
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.